Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • Transparency Market Research
  • October 2020
  • Therapeutic Area
  • 183 pages

Report Description

Global Human Vaccine Market - Scope of Report

TMR’s report on the global human vaccine market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global human vaccine market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global human vaccine market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global human vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global human vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global human vaccine market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global human vaccine market.

The report delves into the competitive landscape of the global human vaccine market. Key players operating in the global human vaccine market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global human vaccine market that have been profiled in this report.

Key Questions Answered in Global Human vaccine Market Report

  • What is the scope of growth of product companies in the global human vaccine market?
  • What will be the Y-o-Y growth of the global human vaccine market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global human vaccine market?
  • Will North America continue to be the most profitable market for human vaccine providers?
  • Which factors are anticipated to hamper the growth of the global human vaccine market during the forecast period?
  • Which are the leading companies in the global human vaccine market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global human vaccine market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global human vaccine market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the human vaccine market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the human vaccine market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global human vaccine market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global human vaccine market more reliably and accurately.

Regional Segmentation of Human vaccine Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Human Vaccine Market – Segmentation

Vaccine Type

  • Conjugate
  • Recombinant
  • Inactivated
  • Combination
  • Attenuated
  • Others

Product Type

  • Pneumococcal
  • Influenza
  • Hepatitis
  • HPV
  • Meningococcal
  • Rotavirus
  • Measles and Rubella
  • Typhoid
  • Combination
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Drugstores
  • Others

Age Group

  • Pediatrics
  • Adolescents
  • Adults
  • Geriatrics

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Have query on this report?

Make an Enquiry

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Human Vaccine Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Human Vaccine Market Analysis and Forecasts, 2018–2030

5. Key Insights
5.1. Product Overview
5.2. Key Industry Developments
5.3. Emerging Trends in Human Vaccines Market

6. Global Human Vaccine Market Analysis and Forecasts, By Vaccine
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value  Forecast By Vaccine, 2018–2030
6.3.1. Conjugate
6.3.2. Recombinant
6.3.3. Inactivated
6.3.4. Combination
6.3.5. Attenuated
6.3.6. Others
6.4. Market Attractiveness By Vaccine

7. Global Human Vaccine Market Analysis and Forecasts, By Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value  Forecast By Product, 2018–2030
7.3.1. Pneumococcal
7.3.2. Influenza
7.3.3. Hepatitis
7.3.4. HPV
7.3.5. Meningococcal
7.3.6. Rotavirus
7.3.7. Measles and Rubella
7.3.8. Typhoid
7.3.9. Combination
7.3.10. Others
7.4. Market Attractiveness By Product

List of Tables

Table 01 Global Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019–2027
Table 02 Global Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 03 Global Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027
Table 04 Global Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 05 Global Human Vaccines Market Size (US$ Mn) Forecast, by Region, 2019–2027
Table 06 Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019–2027
Table 07 Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 08 Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019–2027
Table 09 Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 10 Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027
Table 11 North America Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019–2027
Table 12 North America Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 13 North America Human Vaccines Market Size (US$) Forecast, by Vaccine Type, 2019–2027
Table 14 North America Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 15 North America Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027
Table 16 Europe Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019–2027
Table 17 Europe Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 18 Europe Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019–2027
Table 19 Europe Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 20 Europe Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027
Table 21 Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019–2027
Table 22 Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 23 Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019–2027
Table 24 Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 25 Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027
Table 26 MEA Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019–2027
Table 27 MEA Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019–2027
Table 28 MEA Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019–2027
Table 29 MEA Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019–2027
Table 30 MEA Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019–2027

 

Success Stories

Our Clients